Correlation Between Pungguk Ethanol and AptaBio Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pungguk Ethanol and AptaBio Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pungguk Ethanol and AptaBio Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pungguk Ethanol Industrial and AptaBio Therapeutics, you can compare the effects of market volatilities on Pungguk Ethanol and AptaBio Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pungguk Ethanol with a short position of AptaBio Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pungguk Ethanol and AptaBio Therapeutics.

Diversification Opportunities for Pungguk Ethanol and AptaBio Therapeutics

0.47
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Pungguk and AptaBio is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Pungguk Ethanol Industrial and AptaBio Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AptaBio Therapeutics and Pungguk Ethanol is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pungguk Ethanol Industrial are associated (or correlated) with AptaBio Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AptaBio Therapeutics has no effect on the direction of Pungguk Ethanol i.e., Pungguk Ethanol and AptaBio Therapeutics go up and down completely randomly.

Pair Corralation between Pungguk Ethanol and AptaBio Therapeutics

Assuming the 90 days trading horizon Pungguk Ethanol Industrial is expected to generate 0.2 times more return on investment than AptaBio Therapeutics. However, Pungguk Ethanol Industrial is 4.96 times less risky than AptaBio Therapeutics. It trades about -0.26 of its potential returns per unit of risk. AptaBio Therapeutics is currently generating about -0.11 per unit of risk. If you would invest  1,054,000  in Pungguk Ethanol Industrial on August 28, 2024 and sell it today you would lose (77,000) from holding Pungguk Ethanol Industrial or give up 7.31% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Pungguk Ethanol Industrial  vs.  AptaBio Therapeutics

 Performance 
       Timeline  
Pungguk Ethanol Indu 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pungguk Ethanol Industrial has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
AptaBio Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AptaBio Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Pungguk Ethanol and AptaBio Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pungguk Ethanol and AptaBio Therapeutics

The main advantage of trading using opposite Pungguk Ethanol and AptaBio Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pungguk Ethanol position performs unexpectedly, AptaBio Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AptaBio Therapeutics will offset losses from the drop in AptaBio Therapeutics' long position.
The idea behind Pungguk Ethanol Industrial and AptaBio Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance